文献速递胸部肿瘤

基于39例循环肿瘤细胞来源异种移植模型重新审视SCLC罕见YAP1亚型

The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report.
PubMed 文献 · J Thorac Oncol · 2020-07-25

该研究在39例表型多样的循环肿瘤细胞来源异种移植(CDX)模型中评估YAP1表达,发现14/39例CDX有YAP1转录本、10例有YAP1蛋白,其中8例强表达局限于罕见非神经内分泌细胞簇;2例CDX在SYN阳性的神经内分泌细胞中弱表达YAP1。提示YAP1主要表达于非神经内分泌细胞,但存在亚型内异质性。

要点

  • 39例CDX中14例有YAP1转录本,10例有YAP1蛋白。
  • 8例CDX的强YAP1表达局限于罕见非神经内分泌细胞簇。
  • 2例CDX在SYN阳性神经内分泌细胞中弱表达YAP1。

核心结论

  • YAP1在SCLC CDX中主要表达于非神经内分泌细胞簇,但39例中2例在神经内分泌细胞表达YAP1。

研究设计与样本

  • 研究纳入39例表型多样的循环肿瘤细胞来源异种移植(CDX)模型,通过RNA测序和免疫组化或多重免疫荧光评估YAP1转录本和蛋白表达。

主要发现

  • RNA测序按四种亚型转录因子归一化后,14/39例CDX检出YAP1表达。
  • 10例CDX表达YAP1蛋白,其中8例强YAP1表达局限于罕见非神经内分泌细胞簇。
  • 体外CDX培养中,缺乏SYP表达的贴壁非神经内分泌细胞表达YAP1。
  • 2例CDX中观察到较弱的细胞YAP1表达,广泛分散于SYP阳性神经内分泌细胞。
  • CDX22P具有相对较高的YAP1表达,为ASCL1神经内分泌亚型且神经内分泌评分低,是该CDX生物库中该亚型的离群值。

局限性

  • 研究为描述性数据,未进行功能研究比较非神经内分泌与低神经内分泌背景下YAP1信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Recent consensus defines four SCLC subtypes on the basis of transcription factor expression: ASCL1, NEUROD1, POU2F3, and YAP1. The rare YAP1 subtype is associated with "neuroendocrine (NE)-low" cells among SCLC cell lines and patient samples. We evaluated YAP1 in 39 patients with phenotypically diverse circulating tumor cell-derived explant (CDX) models and revisited YAP1 in terms of prevalence, cell phenotype, and intertumor and intratumor heterogeneity. METHODS: YAP1 transcript and protein expression were assessed by RNA sequencing and immunohistochemistry or multiplexed immunofluorescence of NE and non-NE CDX subpopulations. Physically separated NE and non-NE CDX ex vivo culture lysates were Western blotted for YAP1, NE marker SYP, and AXL. RESULTS: RNA sequencing normalized for the four subtype transcription factors identified YAP1 expression in 14 of 39 CDX. A total of 10 CDX expressed YAP1 protein, and eight had strong YAP1 expression confined to rare non-NE cell clusters. This was confirmed in ex vivo CDX cultures in which adherent non-NE cells lacking SYP expression expressed YAP1. However, in two CDX, weaker cellular YAP1 expression was observed, widely dispersed in SYP-positive NE cells. CONCLUSIONS: YAP1 was predominantly expressed in non-NE cell clusters in SCLC CDX, but two of 39 CDX expressed YAP1 in NE cells. CDX22P, with relatively high YAP1 expression, is an ASCL1 NE subtype with a low NE score and an outlier within this subtype in our CDX biobank. These descriptive data reveal subtly different YAP1 expression profiles, paving the way for functional studies to compare YAP1 signaling in non-NE and low NE cell contexts for potentially personalized therapeutic approaches.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Pearsall SM, Humphrey S, Revill M, et al. The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report. J Thorac Oncol. 2020. PMID: 32721553. doi:10.1016/j.jtho.2020.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。